JCR Pharmaceuticals Co., Ltd. (TYO:4552)

JCR Pharmaceuticals Ratios and Metrics

Market cap in millions JPY. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jan 21, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	82,705	58,963	107,204	176,306	279,312	443,148
Market Cap Growth	11.84%	-45.00%	-39.19%	-36.88%	-36.97%	52.60%
Enterprise Value	107,550	76,238	112,497	181,176	266,306	440,087
Last Close Price	678.00	476.45	818.17	1320.78	2085.97	3283.79
PE Ratio	-	-	19.47	46.74	19.25	64.30
Forward PE	38.57	18.68	15.47	25.97	25.23	65.14
PS Ratio	2.19	1.78	2.50	5.13	5.47	14.73
PB Ratio	1.70	1.24	1.90	3.36	5.47	11.49
P/TBV Ratio	1.82	1.34	2.04	3.63	5.83	12.61
P/FCF Ratio	-	-	13.77	-	-	79.69
P/OCF Ratio	-	-	11.51	-	30.07	42.85
PEG Ratio	-	1.78	1.78	1.78	1.78	1.78
EV/Sales Ratio	2.85	2.31	2.62	5.28	5.21	14.63
EV/EBITDA Ratio	-	-	10.49	25.98	12.17	43.23
EV/EBIT Ratio	-	-	14.94	36.40	13.36	53.09
EV/FCF Ratio	-10.91	-	14.45	-	-	79.14
Debt / Equity Ratio	0.83	0.80	0.41	0.44	0.35	0.47
Debt / EBITDA Ratio	-	-	2.17	3.27	0.83	1.78
Debt / FCF Ratio	-	-	2.99	-	-	3.26
Asset Turnover	0.35	0.32	0.44	0.36	0.60	0.50
Inventory Turnover	0.49	0.53	0.59	0.54	0.74	0.70
Quick Ratio	0.62	0.58	1.12	0.68	1.11	1.19
Current Ratio	1.18	1.16	1.91	1.34	1.48	1.67
Return on Equity (ROE)	-4.37%	-9.04%	10.17%	7.32%	32.39%	19.37%
Return on Assets (ROA)	-2.17%	-4.13%	4.78%	3.24%	14.58%	8.52%
Return on Invested Capital (ROIC)	-5.05%	-10.26%	9.36%	6.96%	43.48%	21.80%
Return on Capital Employed (ROCE)	-6.00%	-11.20%	10.40%	8.40%	36.20%	18.50%
Earnings Yield	-2.85%	-8.07%	5.14%	2.14%	5.19%	1.55%
FCF Yield	-11.92%	-26.07%	7.26%	-7.46%	-0.73%	1.26%
Dividend Yield	2.88%	4.20%	2.44%	1.51%	0.96%	0.35%
Payout Ratio	-	-	45.40%	72.61%	14.95%	15.71%
Buyback Yield / Dilution	2.11%	1.25%	-0.45%	-0.51%	-0.06%	-0.07%
Total Shareholder Return	4.99%	5.45%	2.00%	1.01%	0.90%	0.28%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.